Rvl Pharmaceuticals Plc

(OTC) RVLPQ

Current Price$0.00

Market Cap$100

Since IPO (2018)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Rvl Pharmaceuticals Plc Financials at a Glance

Market Cap

$100

Revenue (TTM)

$36.92M

Net Income (TTM)

$68.27M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

9.30 (High)

Dividend

$0.00

Beta (Volatility)

9.30 (High)

Price

$0.00

Volume

5,000

Open

$0.00

Price

$0.00

Volume

5,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

9.30 (High)

Price

$0.00

Volume

5,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

RVLPQ News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rvl Pharmaceuticals Plc

Industry

Pharmaceuticals

Sector

Health Care

Employees

125

CEO

Brian A. Markison, CPA

Website

www.rvlpharma.com

Headquarters

Bridgewater, NJ 08807, US

RVLPQ Financials

Key Financial Metrics (TTM)

Gross Margin

81%

Operating Margin

-92%

Net Income Margin

-1%

Return on Equity

Return on Capital

-42%

Return on Assets

-40%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00

Shares Outstanding

111.41M

Volume

5.00K

Avg. Volume

2.85K

Financials (TTM)

Gross Profit

$40.27M

Operating Income

$58.99M

EBITDA

$48.23M

Operating Cash Flow

$37.81M

Capital Expenditure

$752.00K

Free Cash Flow

$38.56M

Cash & ST Invst.

$44.54M

Total Debt

$57.49M

Rvl Pharmaceuticals Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2023YOY CHG

Revenue

$8.26M

-2.2%

Gross Profit

$6.31M

+2.7%

Gross Margin

76.43%

N/A

Market Cap

$100.00

N/A

Market Cap/Employee

$0.80

N/A

Employees

125

N/A

Net Income

$23.89M

-97.3%

EBITDA

$20.75M

-92.9%

Quarterly Fundamentals

Name

Q2 2023YOY CHG

Net Cash

$38.99M

-129.4%

Accounts Receivable

$1.93M

+5.4%

Inventory

$1.36M

+156.8%

Long Term Debt

$192.00K

-99.6%

Short Term Debt

$57.95M

+4896.1%

Return on Assets

-40.22%

N/A

Return on Invested Capital

-41.99%

N/A

Free Cash Flow

$13.11M

-756.7%

Operating Cash Flow

$12.06M

-704.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VSMDVasamed, Inc.

VSMDVasamed, Inc.$0.00+0.00%

RCARRenovaCare, Inc.

RCARRenovaCare, Inc.$0.00+0.00%

TRVNTrevena, Inc.

TRVNTrevena, Inc.$0.01+0.00%

GNLKQGeneLink, Inc.

GNLKQGeneLink, Inc.$0.00+0.00%

VAXXVaxxinity, Inc.

VAXXVaxxinity, Inc.$0.00+0.00%

SCPSScopus BioPharma Inc.

SCPSScopus BioPharma Inc.$0.00+0.00%

VRAYQViewRay, Inc.

VRAYQViewRay, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$15.47+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

INTCIntel

INTCIntel$119.84+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

ACHRArcher Aviation

ACHRArcher Aviation$6.36+0.04%

INFQInfleqtion

INFQInfleqtion $16.35+0.11%

Questions About RVLPQ

What is the current price of Rvl Pharmaceuticals Plc?

Rvl Pharmaceuticals Plc is trading at N/A per share.

What is the 52-week range for Rvl Pharmaceuticals Plc?

Over the past 52 weeks, Rvl Pharmaceuticals Plc has traded between N/A and $0.00.

How much debt does Rvl Pharmaceuticals Plc have?

As of the most recent reporting period, Rvl Pharmaceuticals Plc reported total debt of $57.49M.

How much cash does Rvl Pharmaceuticals Plc have on hand?

Rvl Pharmaceuticals Plc reported $44.54M in cash and cash equivalents in its most recent financial results.

What is Rvl Pharmaceuticals Plc’s dividend yield?

Rvl Pharmaceuticals Plc does not currently have a dividend yield.

Rvl Pharmaceuticals Plc

Rvl Pharmaceuticals Plc Financials at a Glance

RVLPQ News

Why Osmotica Pharmaceuticals Stock Plunged Today

Why Osmotica Pharmaceuticals Is Plunging Today

Why Osmotica Pharmaceuticals Jumped Today

These 2 Pharma Stocks Could Be Top Stocks in 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Rvl Pharmaceuticals Plc

RVLPQ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Rvl Pharmaceuticals Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RVLPQ

What is the current price of Rvl Pharmaceuticals Plc?

What is the 52-week range for Rvl Pharmaceuticals Plc?

How much debt does Rvl Pharmaceuticals Plc have?

How much cash does Rvl Pharmaceuticals Plc have on hand?

What is Rvl Pharmaceuticals Plc’s dividend yield?

Premium Investing Services